At this time, InsideTracker is not adding lipid particle size. Although research supports that lipid particle size is predictive of cardiovascular and metabolic health, there is currently limited evidence that lipid particle size is superior to LDL cholesterol in health outcome prediction. Further research is required to determine if interventions to improve one’s lipid particle size distribution are effective. Additionally, ApoB is a strong predictor of cardiovascular outcomes and metabolic health (and potentially even stronger than LDL-p) and therefore does not provide altered context to one's cardiovascular disease risk. InsideTracker’s science team continues to stay up-to-date on the latest research.